NEW YORK, Jan. 04, 2022 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that its existing term loan facility agreement with Hercules Capital, Inc. (NYSE: HTGC), has been ...
Fintel reports that on July 24, 2023, Goldman Sachs maintained coverage of TG Therapeutics (NASDAQ:TGTX) with a Sell recommendation. As of July 6, 2023, the average one-year price target for TG ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback